Variability of protein level and phosphorylation status caused by biopsy protocol design in human skeletal muscle analyses

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Caron, Marc André ^a   Charette, Steve J ^a,b   Maltais, François ^a   Debigaré, Richard ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EUKARYOTA;

EID: 80755189611     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-488     Document Type: Article

References (29)

1. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. Lecker SH, Solomon V, Mitch WE, Goldberg AL, J Nutr 1999 129 227S 237S 9915905 (Pubitemid 29035981)
2. Mechanisms of cancer cachexia. Tisdale MJ, Physiol Rev 2009 89 381 410 10.1152/physrev.00016.2008 19342610
3. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Debigare R, Cote CH, Maltais F, Am J Respir Crit Care Med 2001 164 1712 1717 11719314 (Pubitemid 33124163)
4. Wasting as independent risk factor for mortality in chronic heart failure. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ, Lancet 1997 349 1050 1053 10.1016/S0140-6736(96)07015-8 9107242 (Pubitemid 27158249)
5. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Marquis K, Debigaré R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F, Am J Respir Crit Care Med 2002 166 809 813 10.1164/rccm.2107031 12231489
6. Update on emerging drugs for cancer cachexia. Murphy KT, Lynch GS, Expert Opin Emerg Drugs 2009 14 619 632 10.1517/14728210903369351 19860537
7. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Glass DJ, Nat Cell Biol 2003 5 87 90 10.1038/ncb0203-87 12563267 (Pubitemid 36204186)
8. Signaling in muscle atrophy and hypertrophy. Sandri M, Physiology (Bethesda) 2008 23 160 170 10.1152/physiol.00041.2007
9. Identification of ubiquitin ligases required for skeletal muscle atrophy. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ, Science 2001 294 1704 1708 10.1126/science.1065874 11679633 (Pubitemid 33104839)
10. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. Leger B, Cartoni R, Praz M, Lamon S, Deriaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F, Russell AP, J Physiol 2006 576 923 933 10.1113/jphysiol.2006.116715 16916907 (Pubitemid 44637894)
11. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Doucet M, Russell AP, Léger B, Debigaré R, Joanisse DR, Caron MA, LeBlanc P, Maltais F, Am J Respir Crit Care Med 2007 176 261 269 10.1164/rccm.200605-704OC 17478621 (Pubitemid 47195876)
12. Muscle electrolytes in man. Determined by neutron activation analysis on needle biopsy specimens. A study on normal subjects, kidney patients, and patients with chronic diarrhaea. Bergstrom J, Scand J Clin Lab Invest 1962 14 110
13. Decrease in Akt/PKB signalling in human skeletal muscle by resistance exercise. Deldicque L, Atherton P, Patel R, Theisen D, Nielens H, Rennie MJ, Francaux M, Eur J Appl Physiol 2008 104 57 65 10.1007/s00421-008-0786-7 18535836
14. Nutrient signalling in the regulation of human muscle protein synthesis. Fujita S, Dreyer HC, Drummond MJ, Glynn EL, Cadenas JG, Yoshizawa F, Volpi E, Rasmussen BB, J Physiol 2007 582 813 823 10.1113/jphysiol.2007.134593 17478528 (Pubitemid 47040563)
15. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, Belleau R, Maltais F, Med Sci Sports Exerc 1998 30 1467 1474 10.1097/00005768-199810000-00001 9789845 (Pubitemid 28465510)
16. Protein quantification by chemiluminescent Western blotting: elimination of the antibody factor by dilution series and calibration curve. Charette SJ, Lambert H, Nadeau PJ, Landry J, J Immunol Methods 2010 353 148 150 10.1016/j.jim.2009.12.007 20035759
17. ImageJ, U.S. National Institutes of Health. Rasband WS, Bethesda, Maryland, USA 1997 http://rsbinfonihgov/ij/
18. Impairment in short-term but enhanced long-term synaptic potentiation and ERK activation in adult hippocampal area CA1 following developmental thyroid hormone insufficiency. Sui L, Anderson WL, Gilbert ME, Toxicol Sci 2005 85 647 656 10.1093/toxsci/kfi095 15673845 (Pubitemid 40614294)
19. Regulation of the Akt kinase by interacting proteins. Du K, Tsichlis PN, Oncogene 2005 24 7401 7409 10.1038/sj.onc.1209099 16288287 (Pubitemid 41637980)
20. A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle. Crossland H, Constantin-Teodosiu D, Gardiner SM, Constantin D, Greenhaff PL, J Physiol 2008 586 5589 5600 10.1113/jphysiol.2008.160150 18818241
21. Tumor necrosis factor-{alpha} decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Medina EA, Afsari RR, Ravid T, Castillo SS, Erickson KL, Goldkorn T, Endocrinology 2005 146 2726 2735 10.1210/en.2004-1074 15746249 (Pubitemid 40695576)
22. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL, FASEB J 2004 18 39 51 10.1096/fj.03-0610com 14718385 (Pubitemid 38076464)
23. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Huang LE, Gu J, Schau M, Bunn HF, Proc Natl Acad Sci USA 1998 95 7987 7992 10.1073/pnas.95.14.7987 9653127 (Pubitemid 28326053)
24. Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis. Koyama S, Hata S, Witt CC, Ono Y, Lerche S, Ojima K, Chiba T, Doi N, Kitamura F, Tanaka K, Abe K, Witt SH, Rybin V, Gasch A, Franz T, Labeit S, Sorimachi H, J Mol Biol 2008 376 1224 1236 10.1016/j.jmb.2007.11.049 18222470
25. Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. Greenhaff PL, Karagounis LG, Peirce N, Simpson EJ, Hazell M, Layfield R, Wackerhage H, Smith K, Atherton P, Selby A, Rennie MJ, Am J Physiol Endocrinol Metab 2008 295 595 604 10.1152/ajpendo.90411.2008 18577697
26. During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, Gartner C, Latres E, Goldberg AL, J Cell Biol 2009 185 1083 1095 10.1083/jcb.200901052 19506036
27. TNF-alpha increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK. Plaisance I, Morandi C, Murigande C, Brink M, Am J Physiol Endocrinol Metab 2008 294 241 50 17971516
28. Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2. Chibalin AV, Yu M, Ryder JW, Song XM, Galuska D, Krook A, Wallberg-Henriksson H, Zierath JR, Proc Natl Acad Sci USA 2000 97 38 43 10.1073/pnas.97.1.38 10618367 (Pubitemid 30055780)
29. In vivo differential effects of fasting, re-feeding, insulin and insulin stimulation time course on insulin signaling pathway components in peripheral tissues. Agouni A, Owen C, Czopek A, Mody N, Delibegovic M, Biochem Biophys Res Commun 2010 401 104 111 10.1016/j.bbrc.2010.09.018 20833131